GLP Bioanalysis INVITROX offers GLP-compliant bioanalytical services with capabilities in LC-MS/MS, immunoassays, metabolite profiling, and in vitro ADME, presenting a compelling one-stop partner for preclinical and clinical program support.

Expanded DMPK Reach Strong DMPK and PK/PD modeling capabilities including rodent, canine, and non-human primate studies, plus Phoenix WinNonlin modeling, enabling end-to-end pharmacokinetic analysis and data interpretation for drug development programs.

Small Firm Agility Compact team (11-50 employees) in a modern 4000 sq ft RTP, NC facility, offering potential for fast communication, customized services, and flexible engagement models to complement larger CROs.

Full Instrumentation Suite Laboratory equipped with UPLC/HPLC-MS systems, GC, FT-IR, fluorescence, plate readers, and UV detectors, enabling a broad range of analytical assays to support diverse client needs without outsourcing.

Growth Opportunities Current revenue under 1M with proximity to major CROs and biopharma players suggests expansion potential through scalable bioanalysis, lead optimization, biomarker services, and therapeutic drug monitoring collaborations.